Galapagos | GLPG - Ordinary Share Capital

Stock Price
29.02
Daily Change
0.12 0.43%
Monthly
6.31%
Yearly
31.80%
Q1 Forecast
27.75

Galapagos reported EUR65.9M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 1.16B Sep/2025
Biogen USD 146.7M 200K Sep/2025
Genmab DKK 10M 56M Mar/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
GRIFOLS EUR 679.73M 0 Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Incyte USD 196.13M 2.01M Sep/2025
Merck EUR 434.78M 130.22M Jun/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025